Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Gastric Cancer × dacomitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 7 Brain Neoplasms 3 Recurrence 2 Neoplasm Metastasis 2 Head and Neck Neoplasms 2 Glioblastoma 2 Carcinoma, Squamous Cell 2 Squamous Cell Carcinoma of Head and Neck 1 Rare Tumor 1 Penile Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 NSCLC 1 Lung Neoplasms 1 Carcinoma 1 Advanced Gastric Cancer 1

Interventions

Oxaliplatin 5 Paclitaxel 4 Capecitabine 4 Fluorouracil 3 apatinib 2 S 1 (combination) 2 Leucovorin 2 Docetaxel 2 Cisplatin 2 titanium silicide 1 rucaparib 1 relatlimab 1 raltitrexed 1 pazopanib 1 olaparib 1 linrodostat 1 endostar protein 1 durvalumab 1 dacomitinib 1 capivasertib 1 camrelizumab 1 Sunitinib 1 Nivolumab 1 Ipilimumab 1 HMPL-013 1 Epirubicin 1 CF regimen 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01152853 2015-11-20

PF299804-AGC

Seoul National University Hospital

Phase 2 Completed

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡